Marché de la gastroparésie – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00008992
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 155
Buy Now

[Rapport de recherche]Le marché de la gastroparésie était évalué à 4 338,61 millions de dollars US en 2019 et devrait atteindre 6 025,11 millions de dollars US d'ici 2027 ; il devrait croître à un TCAC de 4,3 % de 2020 à 2027. La gastroparésie est une affection médicale caractérisée par l'incapacité de l'estomac à se vider de la nourriture de la manière habituelle. Les nerfs endommagés tels que les nerfs vagues et les muscles associés à la motilité gastrique peuvent également entraîner une gastroparésie. La condition est couramment observée chez les personnes diabétiques. La gastroparésie peut être classée comme diabétique, idiopathique et post-chirurgicale sur la base de la cause. En dehors de cela, les infections virales, les maladies liées aux nerfs, la consommation excessive de narcotiques et de plusieurs antidépresseurs, ainsi que l'amylose peuvent également entraîner l'apparition d'une gastroparésie.



La pandémie de COVID-19 a perturbé la chaîne d'approvisionnement - les médicaments en vente libre et sur ordonnance, ce qui devrait limiter la croissance du marché au cours des prochains trimestres. De plus, l'accent mis par les prestataires de soins de santé et les industries médicales sur le COVID-19 a conduit à une moindre concentration sur le diagnostic et le traitement de la gastroparésie, ce qui limite dans une certaine mesure la croissance du marché.



Régions lucratives pour Marché de la gastroparésie



Aperçu du marché



L'augmentation de la population gériatrique accélère la demande de modalités de traitement de la gastroparésie



La vidange gastrique est associée à la coordination entre l'activité motrice de l'estomac proximal, distal l'estomac et le duodénum. Ces organes internes sont contrôlés par le mécanisme de rétroaction des signaux neuronaux générés par l'interaction entre les nutriments et l'intestin grêle. Le vieillissement entraîne une diminution des régulations homéostatiques des fonctions physiologiques, ainsi qu'un ralentissement de la vidange gastrique. De plus, il influence les fonctions motrices et sensorielles. De plus, la population gériatrique est très vulnérable à la gastroparésie en raison de facteurs tels que la mauvaise absorption des médicaments par voie orale, la régulation inadéquate de l'appétit et la glycémie postprandiale. Selon la révision 2019 des World Population Prospects, 1 personne sur 6 serait âgée de plus de 65 ans en 2050, avec une augmentation par rapport à 1 sur 11 en 2019. De plus, selon la même étude, une personne sur quatre en Europe et en Amérique du Nord devrait être âgée de plus de 65 ans d'ici 2050. En outre, le nombre de personnes âgées de plus de 80 ans atteindrait 426 millions d'ici 2050 contre 143 millions en 2019. Ainsi, l'augmentation continue du vieillissement de la population, associée à l'augmentation des problèmes liés à la vidange gastrique parmi ces populations, entraîne la croissance du marché de la gastroparésie.



Insights basés sur le type



Sur la base du type, le marché de la gastroparésie est segmenté en idiopathique, diabétique, post-chirurgical, et d'autres. Le segment idiopathique détenait la plus grande part du marché en 2019, tandis que le segment diabétique devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.



Marché de la gastroparésie, par type - 2019 et 2027



< h3>Aperçus basés sur le type de classe de médicaments

Le marché de la gastroparésie, basé sur le type de classe de médicaments, est segmenté en agents procinétiques, agents antiémétiques et injections de toxine botulique. Le segment des agents procinétiques détenait la plus grande part de marché en 2019 et devrait enregistrer le TCAC le plus élevé de 2020 à 2027.



Insights basés sur le canal de distribution



Sur la base du canal de distribution, le marché de la gastroparésie est segmenté en pharmacies hospitalières, pharmacies de détail et autres. Le segment des pharmacies hospitalières détenait la plus grande part du marché en 2019, et on estime que ce marché devrait croître au TCAC le plus élevé de 2020 à 2027.



Perspectives stratégiques



Le Les acteurs du marché de la gastroparésie ont adopté la stratégie d'innovations de produits pour répondre aux demandes dynamiques des clients, ce qui leur permet également de maintenir leur marque sur le marché mondial.



Marché de la gastroparésie - par type



  • Idiopathique

  • Diabétique

  • Post-chirurgicale

  • Autres

Marché de la gastroparésie - par type de classe de médicaments< /h3>

  • Agents procinétiques

  • Injections de toxine botulique

  • Agents antiémétiques

Marché de la gastroparésie - par canal de distribution


  • Pharmacies hospitalières

  • Pharmacies de détail

  • Autres

Marché de la gastroparésie - par géographie



  • Amérique du Nord

    • États-Unis

    • Canada

    • Mexique


  • Europe

    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste de l'Europe


  • Asie-Pacifique (APAC)

    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'APAC


  • Moyen-Orient et Afrique (MEA)

    • Afrique du Sud

    • Arabie saoudite

    • EAU

    • Reste de la MEA


  • Amérique du Sud et Amérique centrale (SCAM)

    • Brésil
    • Argentine

    • Reste de SCAM


Profils d'entreprises




  • EVOKE PHARMA
  • Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)

  • Johnson and Johnson Services, Inc.

  • Allergan Plc

  • NEUROGASTRX, INC

  • TEVA PHARMACEUTICAL INDUSTRIES LTD

  • Pfizer Inc.

  • ANI Pharmaceuticals, Inc.

  • Ipca Laboratories Ltd.
  • < li>Cinrx Pharma, LLC (Cindome Pharma)
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is gastroparesis?

Gastroparesis is a condition where the stomach cannot empty itself of food in the usual way. Moreover, the damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is substantially observed in the diabetic population. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of causes. Apart from these viral infections, nerve-related diseases, excessive consumption of narcotics and some antidepressants, and amyloidosis may also lead to the occurrence of gastroparesis.

What are the driving factors for the gastroparesis market across the globe?

The growth of the market is attributed to some key driving factors such as increasing prevalence of diabetes and growing geriatric population.

Who are the major players in the gastroparesis market?

The gastroparesis market majorly consists of the players such as EVOKE PHARMA, Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., And Cinrx Pharma, LLC (Cindome Pharma) amongst others.

The List of Companies - Gastroparesis Market

  1. EVOKE PHARMA
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Johnson and Johnson Services, Inc.
  4. Allergan Plc
  5. NEUROGASTRX, INC.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD
  7. Pfizer Inc.
  8. ANI Pharmaceuticals, Inc.
  9. Ipca Laboratories Ltd.
  10. Cinrx Pharma, LLC (Cindome Pharma)  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports